GSK exec accused of bribery

Share this article:

The former head of GlaxoSmithKline's China division has been accused of bribery. Bloomberg reports that Mark Reilly has been accused of ordering employees to bribe doctors, hospitals and medical groups to boost drug sales.

GSK told Bloomberg that they cooperating with authorities. The drugmaker noted earlier this year that corruption allegations have inflicted damage on regional sales.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.